肺癌所致胸腔积液的诊断及治疗
发布时间:2018-03-05 06:49
本文选题:恶性肿瘤 切入点:胸腔积液 出处:《吉林大学》2015年硕士论文 论文类型:学位论文
【摘要】:目的: 探讨肺癌所致胸腔积液的诊断及治疗。 方法: 在2014年3月-2015年3月我科收治的胸腔积液病人中筛选出肺癌所致胸腔积液患者86名,经检查,诊断,治疗及动态疗效观察,对比不同年龄、不同性别、不同部位、不同病理类型和组织类型肺癌患者胸腔积液的发病率和治疗效果。利用统计学方法进行分析。总结出肺癌引起胸腔积液的临床特点,为此类病患的诊治提供借鉴。 结果: 一般资料比较:患者年龄、性别、一般状态、肺癌的类型、肺癌的部位、肺癌大小等,经过比较究结果表明:肺癌患者中腺癌产生胸腔积液明显多于其他细胞类型;周围型肺癌患者胸腔积液产生明显多于中心型肺癌患者;与肺癌大小无关。年龄、性别等情况对肺癌患者胸腔积液的产生影响不大。肺癌所致胸腔积液胸腔引流后胸腔注射胸膜粘连剂,,使胸腔积液的复发率明显降低。所以胸膜粘连剂在治疗肺癌所致胸腔积液中起到较明显效果,值得推广使用。在其他原因引起的反复性胸腔积液中也可以考虑应用胸膜粘连剂,尤其恶性肿瘤原因引起的胸腔积液。 结论: 恶性胸腔积液是恶性肿瘤胸膜转移的结果。通过胸部X线片、胸部CT、胸腔超声检查、诊断性试穿可明确胸腔积液的诊断。细胞学检查发现肺癌细胞可明确肺癌所致胸腔积液的诊断。患者如能早期得到确诊,并进行积极正确的治疗,延长患者生存时间,提高患者的生存质量是可以实现的。目前对恶性胸腔积液的治疗包括胸腔引流,胸膜粘连等方法仍然是治疗胸腔积液的最有效的方法,但不能使恶性肿瘤本身得到控制。
[Abstract]:Objective:. To investigate the diagnosis and treatment of pleural effusion caused by lung cancer. Methods:. From March 2014 to March 2015, 86 patients with pleural effusion caused by lung cancer were selected from our department. The incidence and therapeutic effect of pleural effusion in lung cancer patients with different pathological types and tissue types were analyzed by statistical method. The clinical characteristics of pleural effusion caused by lung cancer were summarized, which provided a reference for the diagnosis and treatment of lung cancer patients. Results:. Comparison of general data: age, sex, general state, type of lung cancer, location of lung cancer, size of lung cancer, etc. The results showed that adenocarcinoma produced more pleural effusion than other cell types in patients with lung cancer. The pleural effusion in patients with peripheral lung cancer was significantly higher than that in patients with central lung cancer; it had nothing to do with the size of lung cancer. Sex has little effect on pleural effusion in patients with lung cancer. After pleural drainage, pleural adhesives were injected into the pleural cavity of lung cancer patients. The recurrence rate of pleural effusion was obviously reduced. Therefore, pleural adhesives have obvious effect in treating pleural effusion caused by lung cancer, and are worth popularizing. Pleural adhesives can also be considered in recurrent pleural effusion caused by other reasons. Especially the pleural effusion caused by malignant tumor. Conclusion:. Malignant pleural effusion is the result of pleural metastasis of malignant tumor. The diagnostic test can confirm the diagnosis of pleural effusion. Cytological examination shows that lung cancer cells can confirm the diagnosis of pleural effusion caused by lung cancer. If the patient can be diagnosed at an early stage and receive positive and correct treatment to prolong the survival time of the patient, At present, the treatment of malignant pleural effusion, including pleural drainage and pleural adhesion, is still the most effective method for the treatment of pleural effusion, but the malignant tumor itself cannot be controlled.
【学位授予单位】:吉林大学
【学位级别】:硕士
【学位授予年份】:2015
【分类号】:R734.2
【参考文献】
相关期刊论文 前8条
1 Kuang-Rong Wei;Xia Yu;Rong-Shou Zheng;Xia-Biao Peng;Si-Wei Zhang;Ming-Fang Ji;Zhi-Heng Liang;Zhi-Xiong Ou;Wan-Qing Chen;;Incidence and mortality of liver cancer in China, 2010[J];Chinese Journal of Cancer;2014年08期
2 王彩英;张映铭;;洛铂联合足叶乙甙治疗晚期小细胞肺癌的临床研究[J];临床肺科杂志;2009年08期
3 杨柳青;秦叔逵;;第3代铂类药物洛铂的研究新进展[J];临床肿瘤学杂志;2009年12期
4 郝可可;朱际平;于力克;;Survivin检测在肺癌胸腔积液诊断中的临床价值[J];山东大学学报(医学版);2010年12期
5 赵昌林;程少冰;李恒谋;;恶性肿瘤放化疗对机体损伤的病因病机分析[J];山东中医杂志;2010年01期
6 欧红萍;周凤勤;;超声在胸腔积液诊断中的应用价值[J];临床和实验医学杂志;2013年14期
7 刘粉霞;;中心静脉导管在恶性胸腔积液治疗中的应用[J];现代肿瘤医学;2014年01期
8 廉政君;黄建国;;晚期非小细胞肺癌预后相关因素分析[J];现代肿瘤医学;2014年01期
本文编号:1569182
本文链接:https://www.wllwen.com/yixuelunwen/zlx/1569182.html